Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup

Article Abstract:

Children with croup may benefit from budesonide or dexamethasone. These drugs belong to the group known as corticosteroids. Researchers randomly assigned 144 children with croup to receive aerosolized budesonide, intramuscular dexamethasone or a placebo. Over a five-hour period following treatment, the children who received budesonide or dexamethasone had a greater improvement in symptoms than those who received a placebo. Hospitalization rates were also substantially lower in the children who received corticosteroids.

Author: Schuh, Suzanne, Johnson, David W., Jacobson, Sheila, Edney, Peter C., Hadfield, Pat, Mundy, Marianne E.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial

Article Abstract:

Dexamethasone appears to be the preferred treatment for croup because of its low cost and availability. Croup is an upper respiratory disease characterized by hoarseness, difficulty breathing and a barking cough. Researchers randomly assigned 197 children with croup to receive dexamethasone, budesonide or both drugs. The outcome in all three groups was similar. Since dexamethasone is more readily available in emergency departments, it may be the drug of choice for treating croup.

Author: Moher, David, Rowe, Peter C., Pasterkamp, Hans, Klassen, Terry P., Craig, William R., Osmond, Martin H., Sutcliffe, Terry, Watters, Lise K.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A randomized trial of a single dose of oral dexamethasone for mild croup

Article Abstract:

A doubled-blind trial at four pediatric emergency departments is conducted in which 720 children with mild croup are randomly assigned to receive one oral dose of either dexamethasone or placebo. Dexamethasone for children with mild croup proves to be an effective treatment that results in consistent and small but important clinical and economic benefits.

Author: Brant, Rollin, Bjornson, Candice L., Klassen, Terry P., Johnson, David W., Williamson, Janielee, Evered, Lisa, Bolloch, Blake, Mitton, Craig, Plin, Amy
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Science & research, Research, Pediatric diseases, Children, Dosage and administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Drug therapy, Dexamethasone, Budesonide, Croup
Similar abstracts:
  • Abstracts: Participation of international medical graduates in graduate medical education and hospital care for the poor
  • Abstracts: A comparison of endothelium-dependent relaxation in omental and myometrial resistance arteries in pregnant and nonpregnant
  • Abstracts: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
  • Abstracts: Effect of race on insurance coverage and health service use for HIV-infected gay men. Managed care for AIDS patients: Is bigger better?
  • Abstracts: A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.